HPLC detection of plasma concentrations of diclofenac in human volunteers administered with povidone-ethylcellulose-based experimental transdermal matrix-type patches

Methods and Findings in Experimental and Clinical Pharmacology

Volumn 28, Issue 5, 2006, Pages 301-306

  Mukherjee, Biswajit ^a   Mahapatra, S ^a   Das, S ^a   Roy, G ^a   Dey, S ^b  

^a JADAVPUR UNIVERSITY   (India)

^b CHITTARANJAN NATIONAL CANCER INSTITUTE   (India)

Author keywords

Diclofenac diethylamine; High performance liquid chromatography; Human volunteer; Plasma; Transdermal patch

Indexed keywords

DICLOFENAC; DICLOFENAC DIETHYLAMINE; ETHYL CELLULOSE; POVIDONE;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; IN VIVO STUDY; MALE; NORMAL HUMAN; SCANNING ELECTRON MICROSCOPY;

ADMINISTRATION, CUTANEOUS; ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHEMISTRY, PHARMACEUTICAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DICLOFENAC; EXCIPIENTS; FEMALE; HUMANS; MALE; POVIDONE;

EID: 33745906544     PISSN: 03790355     EISSN: None     Source Type: Journal    
DOI: 10.1358/mf.2006.28.5.1000338     Document Type: Article

References (22)

1. Zuckner, J. International experience with diclofenac in rheumatoid arthritis. Am J Med 1986, 80: 39-42.
2. Piccinini, F., Rovati, L., Zanni, A., Cagnacci, A., Volpe, A., Facchhinetti, F. Indirect evidence that estrogen replacement therapy stimulates nitric oxide synthetase in postmenopausal women. Gynaecol Endocrinol 2000, 14: 142-6.
3. Moya, R.A., Moisa, C.F., Morales, F., Wynter, H., Narancis, E. Transdermal glyceryl trinitrate in the management of primary dysmenorrheal. Int J Gynaecol Obstet 2000, 69: 113-18.
4. Ku, E.C., Wasvary, J.M., Cash, W.D. Diclofenac sodium (GP 45840, VollarenTM) a potent inhibitor of prostaglandin synthetase. Biochem Pharmacol 1975, 24: 641-3.
5. Lundstam, S., Leissner, K.H., Wahlander, L., Kral, J.G. Inhibition of prostaglandin synthesis by diclophenac-Na in renal calculus pain. Lakartidningen 1983, 80: 4789-90.
6. French, L. Dysmenorrhea. Am Fam Physician 2005, 71: 285-91.
7. Riviere, J.E., Papich, M.G. Potential and problems of developing transdermal patches for veterinary applications. Adv Drug Deliv Rev 2000, 50: 175-203.
8. Zevin, S., Jacob, P., III, Benowitz, N.L. Nicotine-mecarylaim interaction. Clin Pharmacol Ther 2000, 68: 58-66.
9. Arora, P., Mukherjee, B. Design, development, physicochemical and in vitro evaluation of transdermal patches containing diclofenac diethylamine. J Pharm Sci 2002, 91: 2076-89.
10. Hayton, W.L., Levy, G., Regardh, C.G. Effect of complex formation on drug absorption. XIV. Effect of N,N-di-n-propyl-propionamide on intestinal absorption of certain nonsteroid drugs in the rat. J Pharm Sci 1972, 61: 473-4.
11. Dalby, R. www.pharmacy.umaryland.edu/faculty (accessed October 24, 2003).
12. Assandri, A., Bernareggi, A., Ripamonti, A., Perazzi, A., Toja, E. Pharmacokinetics and metabolism of tomoxiprole, a new analgesic antiinflammatory agent, in the rat. Eur J Drug Metab Pharmacokinet 1985, 10: 161-70.
13. Hui, X., Hewitt, P.G., Poblete, N., Maibach, H.I., Shainhouse, J.Z., Wester, R.C. In vivo bioavailability and metabolism of topical diclofenac lotion in human volunteers. Pharm Res 1998, 15: 1589-95.
14. Krzek, J., Starek, M. Densitometric determination of diclofenac, 1-(2,6-dichlorophenyl) indolin-2-one and indolin-2-one in pharmaceutical preparations and model solutions. J Pharm Biomed Anal 2002, 28: 227-43.
15. Ikeda, M., Kawase, M., Hiramatsu, M., Hirota, K., Ohmori, S. Improved gas Chromatographic method for determining diclofenac in plasma. J Chromatogr 1980, 183: 41-7.
16. Stevens, AJ., Martin, S.W., Brennan, B.S. et al. Regional drug delivery II: relationship between drug targeting index and pharmacokinetic parameters for three non-steroidal antiinflammatory drugs using the rat air pouch model of inflammation. Pharm Res 1995, 12: 1987-96.
17. Zecca, L., Ferrario, P., Costi, P. Determination of didofenac and its metabolites in plasma and cerebrospinal fluid by high-performance liquid chromatography with electrochemical detection. J Chromatogr 1991, 567: 425-32.
18. Kuhlmann, O., Stoldt, G., Struck, H.G., Krauss, G.J. Simultaneous determination of didofenac and oxyhuprocaine in human aqueous humor with HPLC and electrochemical detection. J Pharm Biomed Anal 1998, 17: 1351-6.
19. El Sayed, Y.M., Hameed, M.E.B., Suleman, N.M. A rapid and sensitive high-performance liquid Chromatographic method for the determination of didofenac sodium in serum and its use in pharmacokinetic studies. J Pharm Pharmacol 1988, 40: 727-9.
20. Roskar, R., Kmetec, V. Liquid chromatographic determination of didofenac in human synovial fluid. J Chromatogr B Analyt Technol Biomed Life Sci 2003, 788: 57-64.
21. Rossi, D.T., Wright, D.S. Analytical considerations for trace determinations of drugs in breast milk. J Pharm Biomed Anal 1997, 15: 495-504.
22. Radhofer-Welte, S., Dittrich, P. Determination of the novel non-steroidal anti-inflammatory drug lornoxicam and its main metabolite in plasma and synovial fluid. J Chromatogr B Biomed Sci Appl 1998, 707: 151-9.